Skip to main content
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
32.04
-0.62 (-1.90%)
At close: Jul 19, 2024, 4:00 PM
32.09
+0.05 (0.16%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

HRMY Revenue

Harmony Biosciences Holdings had revenue of $617.51M in the twelve months ending March 31, 2024, with 30.92% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $154.62M with 29.79% year-over-year growth. In the year 2023, Harmony Biosciences Holdings had annual revenue of $582.02M with 32.93% growth.

Revenue (ttm)
$617.51M
Revenue Growth
+30.92%
P/S Ratio
2.95
Revenue / Employee
$2,510,207
Employees
246
Market Cap
1.82B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeoGenomics 610.66M
Veracyte 375.47M
Zai Lab 291.07M
Ligand Pharmaceuticals 118.31M
RxSight 101.10M
Keros Therapeutics 234.00K
Revenue Rankings

HRMY News

More News